2nd Edition of International Summit on Hematology and Blood Disorders
June 05-07, 2025
Bone Marrow Transplantation/Hematopoietic Cell Transplantation
Patients with certain malignancies or other disorders may benefit from a bone marrow transplant (BMT). A bone marrow transplant involves extracting cells from the donor's bone marrow (stem cells), screening them, and returning them to the donor (patient) or another person. After a person's own unhealthy bone marrow has been treated to eliminate the aberrant cells, BMT is used to transfuse healthy bone marrow cells into him or her. Since 1968, bone marrow transplantation has been used to treat diseases such leukemias, lymphomas, aplastic anaemia, immune deficiency syndromes, and various solid tumour malignancies.
Hematopoietic stem cell transplantation (HSCT) is an intravenous infusion of hematopoietic stem cells used to restore blood cell production in individuals with damaged or dysfunctional bone marrow or immune systems. This approach has been utilised to treat a variety of malignant and nonmalignant disorders with increasing frequency during the last half-century.
Jie Xu
The University of Texas MD Anderson Cancer Center, United States
Ravishankar Rao Baikady
The Royal Marsden NHS Foundation Trust, United Kingdom
Peter J Van Der Spek
Erasmus University Medical Center, Netherlands
Aida I Richardson
Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Maryam Asif
University of Washington, United States
Raykina Elena
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Santosh Kumar Mondal
Department of Pathology and Laboratory Medicine AIIMS, IndiaSubmit your abstract Today
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia